Your browser doesn't support javascript.
loading
Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial.
Pfeffer, Marc A; Claggett, Brian; Lewis, Eldrin F; Granger, Christopher B; Køber, Lars; Maggioni, Aldo P; Mann, Douglas L; McMurray, John J V; Rouleau, Jean-Lucien; Solomon, Scott D; Steg, Philippe Gabriel; Berwanger, Otavio; Cikes, Maja; De Pasquale, Carmine G; Fernandez, Alberto; Filippatos, Gerasimos; Jering, Karola; Landmesser, Ulf; Menon, Venugopal; Merkely, Béla; Petrie, Mark C; Petrov, Ivo; Schou, Morten; Senni, Michele; Sim, David; van der Meer, Peter; Lefkowitz, Martin; Zhou, Yinong; Wang, Yi; Braunwald, Eugene.
Afiliação
  • Pfeffer MA; Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School Boston, MA (M.A.P., B.C., S.D.S., K.J.).
  • Claggett B; Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School Boston, MA (M.A.P., B.C., S.D.S., K.J.).
  • Lewis EF; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford University, Palo Alto, CA (E.F.L.).
  • Granger CB; Duke University Medical Center, Durham, NC (C.B.G.).
  • Køber L; Rigshospitalet, Blegdamsvej, University of Copenhagen, Denmark (L.K.).
  • Maggioni AP; ANMCO Research Center, Florence, Italy (A.P.M.).
  • Mann DL; Washington University School of Medicine, St. Louis, MO (D.L.M.).
  • McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Scotland (J.J.V.M., M.C.P.).
  • Rouleau JL; Montréal Heart Institute, University of Montréal, Quebec, Canada (J.-L.R.).
  • Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School Boston, MA (M.A.P., B.C., S.D.S., K.J.).
  • Steg PG; Université de Paris, AP-HP (Assistance Publique-Hôpitaux de Paris), FACT (French Alliance for Cardiovascular Trials) and INSERM U-1148, France (P.G.S.).
  • Berwanger O; Academic Research Organization - Hospital Israelita Albert Einstein, São Paulo-SP, Brazil (O.B.).
  • Cikes M; Department of Cardiovascular Diseases, University of Zagreb School of Medicine and University Hospital Centre Zagreb, Croatia (M.C.).
  • De Pasquale CG; Department of Cardiovascular Medicine, Flinders Medical Centre, Adelaide, Australia (C.G.D.P.).
  • Fernandez A; Cardiology Service, Sanatorio Modelo Quilmes, Argentina (A.F.).
  • Filippatos G; HF Unit at the Attikon University Hospital, Athens, Greece (G.F.).
  • Jering K; Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School Boston, MA (M.A.P., B.C., S.D.S., K.J.).
  • Landmesser U; Department of Cardiology, Charité University Medicine Berlin, German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin Institute of Health, Germany (U.L.).
  • Menon V; Cardiovascular Medicine, Cleveland Clinic, OH (V.M.).
  • Merkely B; Semmelweis University, Heart and Vascular Center, Budapest, Hungary (B.M.).
  • Petrie MC; Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School Boston, MA (M.A.P., B.C., S.D.S., K.J.).
  • Petrov I; Acibadem City Clinic Cardiovascular Center, Sofia, Bulgaria (I.P.).
  • Schou M; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark (M. Schou).
  • Senni M; Cardiovascular Department, Hospital Papa Giovanni XXIII, Bergamo, Italy (M. Senni).
  • Sim D; National Heart Centre Singapore (D.S.).
  • van der Meer P; Department of Cardiology, University Medical Center Groningen, University of Groningen, The Netherlands (P.v.d.M.).
  • Lefkowitz M; Novartis Pharmaceutical Corporation, East Hanover, NJ (M.L., Y.Z., Y.W.).
  • Zhou Y; Novartis Pharmaceutical Corporation, East Hanover, NJ (M.L., Y.Z., Y.W.).
  • Wang Y; Novartis Pharmaceutical Corporation, East Hanover, NJ (M.L., Y.Z., Y.W.).
  • Braunwald E; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA (E.B.).
Circulation ; 145(1): 87-89, 2022 01 04.
Article em En | MEDLINE | ID: mdl-34797725
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Bifenilo / Ramipril / Valsartana / Aminobutiratos / Insuficiência Cardíaca / Anti-Hipertensivos Limite: Humans Idioma: En Revista: Circulation Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Bifenilo / Ramipril / Valsartana / Aminobutiratos / Insuficiência Cardíaca / Anti-Hipertensivos Limite: Humans Idioma: En Revista: Circulation Ano de publicação: 2022 Tipo de documento: Article